PUBLIC CONTRACT · 2020
Inffliximab (bios) 100 mg pó conc sol inj fr iv procediemento no 1039920
- Contract value
- €31,500.00
- Signed on
- 24 January 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6406929PUBLISHED SUBJECT
Inffliximab (bios) 100 mg pó conc sol inj fr iv procediemento no 1039920
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PHARMAKERN PORTUGAL-PROD. FARMAC., LDA · Tax ID 507002571
Values and timeline
- Contract price
- €31,500.00
- Procedure base price
- €31,500.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 10 March 2020
- Award date
- 24 January 2020
- Signing date
- 24 January 2020
- Performance period
- 360 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2018/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4449982
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.